NCT04531059View on ClinicalTrials.gov

Rescue Therapy for Helicobacter Pylori Eradication Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

December 20, 2022

Study Completion Date

December 31, 2022

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

Proton pump inhibitor

DRUG

Bismuth Potassium Citrate

Gastric mucosal protective drug with anti-H. pylori effect

DRUG

Tetracycline,Metronidazole

Antibiotics for H. pylori eradication

DRUG

Minocycline,Metronidazole

Antibiotics for H. pylori eradication

Trial Locations (3)

200120

Shanghai East Hospital, Tongji University School of Medicine, Shanghai

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

Unknown

The Second Affiliated Hospital of Zhejiang University school of Medicine, Hangzhou

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT04531059 - Rescue Therapy for Helicobacter Pylori Eradication Treatment | Biotech Hunter | Biotech Hunter